| Purpose | Announcement Date | Ex-Date | Record Date | Dividend Amount | Dividend per Share | Remark |
|---|---|---|---|---|---|---|
| Dividend | 6 May 2024 | 16 Jul 2024 | 16 Jul 2024 | 8 | 400 | Final |
| Approval Of The Audited Financial Statements For The Quarter And Year Ended March 31, 2024 And Recommend Final Dividend @ 400% i.e. Rs. 8/- Per Equity Share Of The Face Value of Rs. 2/- Each For The Year Ended March 31, 2024. Lupin Limited has fixed Tuesday, July 16, 2024, as the Record Date for the purpose of ascertaining the Shareholders who will be entitled to payment of dividend, if declared at the Annual General Meeting (As per BSE Announcement Dated on 04/07/2024) | ||||||
Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide tablets are therapeutic equivalents of Symtuza Tablets 800 mg/150 mg/200 mg/10 mg brand of Janssen Products, LP.
Here are some of the stocks that may see significant price movement today: Tata Motors, BHEL, Hindalco, Lupin, etc.
Lupin was already selling Huminsulin under the license agreement entered with Lilly India.
The approval enables Lupin to offer a generic version of Descovy pills, which were originally produced by Gilead Sciences Inc.
Here are some of the stocks that may see significant price movement today: Reliance Industries, Biocon, Bharat Forge, etc.
Lupin ranks as the third-largest pharmaceutical player in the U.S. by prescriptions and seventh in the Indian Pharmaceutical Market (IPM).
Lupin Limited reports a 77% increase in Q1 net profit to ₹801.3 crores, with total sales up 16.3%.
Here are some of the stocks that may see significant price movement today: Tata Power, Chambal Fertilisers, Cummins India, etc.
Here are some of the stocks that may see significant price movement today: Adani Energy Solutions, Bharti Airtel, Bharti Hexacom, etc.
According to the terms of the agreement, Lupin may receive up to $84 million in total payment based on future dependent milestones.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
